linvoseltamab
Regeneron
['linvoseltamab', 'mmsm']
#asco23 | hans lee, , shares the latest on linvoseltamab. orr 71%, with 30% cr at the rp2d; most patients quad-exposed. lower rates of neutropenia potentially due to the de-escalation for pts in vgpr, but the most common cause of death was still infections. #mmsm 
The Multiple Myeloma (MM) Hub is an online educational resource run in collaboration with the European School of Haematology @ESHaematology #mmsm #myeloma